Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus

Cardiovascular Diabetology

Volumn 7, Issue , 2008, Pages

  Yang, Xilin ^a   Ma, Ronald C ^a   So, Wing Yee ^a   Kong, Alice P ^a   Ko, Gary T ^a   Ho, Chun Shun ^a   Lam, Christopher W ^a   Cockram, Clive S ^a   Tong, Peter C ^a   Chan, Juliana C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CALIBRATION; CARDIOVASCULAR RISK; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DIET THERAPY; FEMALE; FOLLOW UP; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HONG KONG; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROBABILITY; PROCESS DEVELOPMENT; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; ROC CURVE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; VALIDATION STUDY; MIDDLE AGED; PREDICTION AND FORECASTING; REGISTER; REPRODUCIBILITY; RISK FACTOR; STANDARD; STATISTICS;

AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HONG KONG; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGISTRIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 43849097715     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-7-9     Document Type: Article

References (36)

1. Nichols GA Koro CE Gullion CM Ephross SA Brown JB The incidence of congestive heart failure associated with antidiabetic therapies Diabetes Metab Res Rev 2005, 21(1):51-57. 10.1002/dmrr.480 15386819
2. Thrainsdottir IS Aspelund T Thorgeirsson G Gudnason V Hardarson T Malmberg K Sigurdsson G Ryden L The association between glucose abnormalities and heart failure in the population-based Reykjavik study Diabetes Care 2005, 28(3):612-616. 10.2337/diacare.28.3.612 15735197
3. Anderson KM Odell PM Wilson PW Kannel WB Cardiovascular disease risk profiles Am Heart J 1991, 121(1 Pt 2):293-298. 10.1016/ 0002-8703(91)90861-B 1985385
4. Stevens RJ Kothari V Adler AI Stratton IM The UKPDS risk engine: A model for the risk of coronary heart disease in Type II diabetes (UKPDS 56) Clin Sci (Lond) 2001, 101(6):671-679. 11724655
5. Kothari V Stevens RJ Adler AI Stratton IM Manley SE Neil HA Holman RR UKPDS 60: Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine Stroke 2002, 33(7):1776-1781. 10.1161/01.STR.0000020091.07144.C7 12105351
6. Yang XL So WY Kong AP Clarke P Ho CS Lam CW Ng MH Lyu RR Yin DD Chow CC Cockram CS Tong PC Chan JC End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry Diabetologia 2006, 49(10):2299-2308. 10.1007/s00125-006-0376-3 16944095
7. Yang XL So WY Kong AP Ho CS Lam CW Ng MH Lyu RR Yin DD Chow CC Cockram CS Tong PC Chan JC Modified end-stage renal disease risk score for Chinese type 2 diabetic patients--the Hong Kong Diabetes Registry Diabetologia 2007, 50(6):1348-1350. 10.1007/s00125-007-0639-7 17431580
8. Yang X So WY Kong AP Ho CS Lam CW Stevens RJ Lyu RR Yin DD Cockram CS Tong PC Wong V Chan JC Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: The Hong Kong Diabetes Registry Diabetes Care 2007, 30(1):65-70. 10.2337/ dc06-1273 17192335
9. Yang X So WY Kong AP Ma RC Ko GT Ho CS Lam CW Cockram CS Chan JC Tong PC Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus Am J Cardiol 2008, 101(5):596-601. 10.1016/ j.amjcard.2007.10.019 18308005
10. Yang X So WY Tong PC Ma RC Kong AP Lam CW Ho CS Cockram CS Ko GT Chow CC Wong VC Chan JC Development and validation of an all-cause mortality risk score in type 2 diabetes Arch Intern Med 2008, 168(5):451-457. 10.1001/archinte.168.5.451 18332288
11. Piwernetz K Home PD Snorgaard O Antsiferov M Staehr-Johansen K Krans M the DIABCARE Monitoring Group of the St. Vincent Declaration Steering Committee: Monitoring the targets of the St. Vincent Declaration and the implementation of quality management in diabetes care: The DIABCARE initiative Diabet Med 1993, 10:371-377. 8508624
12. Hunt SA Abraham WT Chin MH Feldman AM Francis GS Ganiats TG Jessup M Konstam MA Mancini DM Michl K Oates JA Rahko PS Silver MA Stevenson LW Yancy CW Antman EM Smith SC Jr. Adams CD Anderson JL Faxon DP Fuster V Halperin JL Hiratzka LF Jacobs AK Nishimura R Ornato JP Page RL Riegel B ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society Circulation 2005, 112(12):e154-235. 10.1161/CIRCULATIONAHA.105.167586 16160202
13. Yang X Ma RC So WY Ko GT Kong AP Lam CW Ho CS Cockram CS Wong VC Tong PC Chan JC Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry Cardiovasc Diabetol 2007, 6:37. 2219954 18053157 10.1186/1475-2840-6-37
14. Ma YC Zuo L Chen JH Luo Q Yu XQ Li Y Xu JS Huang SM Wang LN Huang W Wang M Xu GB Wang HY Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J Am Soc Nephrol 2006, 17(10):2937-2944. 10.1681/ASN.2006040368 16988059
15. Ingelsson E Arnlov J Sundstrom J Zethelius B Vessby B Lind L Novel metabolic risk factors for heart failure J Am Coll Cardiol 2005, 46(11):2054-2060. 10.1016/j.jacc.2005.07.059 16325042
16. Lin DY Wei LJ Ying Z Checking the Cox Model with Cumulative Sums of Martingale-Based Residuals Biometrika 1993, 80(3):557-572. 10.1093/ biomet/80.3.557
17. Harrell FE Jr. Lee KL Mark DB Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 1996, 15(4):361-387. 10.1002/ (SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 8668867
18. Pencina MJ D'Agostino RB Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation Stat Med 2004, 23(13):2109-2123. 10.1002/sim.1802 15211606
19. Chambless LE Diao G Estimation of time-dependent area under the ROC curve for long-term risk prediction Stat Med 2006, 25(20):3474-3486. 10.1002/sim.2299 16220486
20. D'Agostino RB Sr. Grundy S Sullivan LM Wilson P Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation JAMA 2001, 286(2):180-187. 10.1001/ jama.286.2.180 11448281
21. Liu J Hong Y D'Agostino RB Sr. Wu Z Wang W Sun J Wilson PW Kannel WB Zhao D Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study JAMA 2004, 291(21):2591-2599. 10.1001/jama.291.21.2591 15173150
22. Guzder RN Gatling W Mullee MA Mehta RL Byrne CD Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: Results from a United Kingdom study Diabet Med 2005, 22(5):554-562. 10.1111/ j.1464-5491.2005.01494.x 15842509
23. Donnan PT Donnelly L New JP Morris AD Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population Diabetes Care 2006, 29(6):1231-1236. 10.2337/ dc05-1911 16732001
24. Chaowalit N Arruda AL McCully RB Bailey KR Pellikka PA Dobutamine stress echocardiography in patients with diabetes mellitus: Enhanced prognostic prediction using a simple risk score J Am Coll Cardiol 2006, 47(5):1029-1036. 10.1016/j.jacc.2005.10.048 16516089
25. Stratton IM Adler AI Neil HA Matthews DR Manley SE Cull CA Hadden D Turner RC Holman RR Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study BMJ 2000, 321(7258):405-412. 27454 10938048 10.1136/ bmj.321.7258.405
26. Tong PC Kong AP So WY Ng MH Yang X Ng MC Ma RC Ho CS Lam CW Chow CC Cockram CS Chan JC Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes Diabetes Care 2006, 29(11):2439-2444. 10.2337/dc06-0887 17065681
27. Horwich TB Fonarow GC Hamilton MA MacLellan WR Borenstein J Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure J Am Coll Cardiol 2002, 39(11):1780-1786. 10.1016/ S0735-1097(02)01854-5 12039491
28. Metivier F Marchais SJ Guerin AP Pannier B London GM Pathophysiology of anaemia: Focus on the heart and blood vessels Nephrol Dial Transplant 2000, 15(Suppl 3):14-18. 11032352
29. Carr AA Kowey PR Devereux RB Brenner BM Dahlof B Ibsen H Lindholm LH Lyle PA Snapinn SM Zhang Z Edelman JM Shahinfar S Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies Am J Cardiol 2005, 96(11):1530-1536. 10.1016/ j.amjcard.2005.07.061 16310435
30. Hockensmith ML Estacio RO Mehler P Havranek EP Ecder ST Lundgren RA Schrier RW Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes J Card Fail 2004, 10(2):126-131. 10.1016/j.cardfail.2003.09.003 15101024
31. Vaur L Gueret P Lievre M Chabaud S Passa P Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: Observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study Diabetes Care 2003, 26(3):855-860. 10.2337/diacare.26.3.855 12610049
32. de Zeeuw D Remuzzi G Parving HH Keane WF Zhang Z Shahinfar S Snapinn S Cooper ME Mitch WE Brenner BM Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy Circulation 2004, 110(8):921-927. 10.1161/01.CIR.0000139860.33974.28 15302780
33. Horwich TB Fonarow GC Hamilton MA MacLellan WR Woo MA Tillisch JH The relationship between obesity and mortality in patients with heart failure J Am Coll Cardiol 2001, 38(3):789-795. 10.1016/ S0735-1097(01)01448-6 11527635
34. Bray GA Health hazards of obesity Endocrinol Metab Clin North Am 1996, 25(4):907-919. 10.1016/S0889-8529(05)70361-3 8977052
35. Stevens RJ Coleman RL Adler AI Stratton IM Matthews DR Holman RR Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66 Diabetes Care 2004, 27(1):201-207. 10.2337/ diacare.27.1.201 14693990
36. King H Aubert RE Herman WH Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 1998, 21(9):1414-1431. 10.2337/diacare.21.9.1414 9727886